Skip to main content

Wichterman Troy's Form 4/A amendment

Amended

Biolife Solutions Inc (BLFS) · filed Feb 17, 2022

Accession no.
0001437749-22-003762
Filed
Feb 17, 2022
Trade date
Dec 22, 2021
Filing delay
57 days
Rule 10b5-1 plan
Not on the form (before 2023)
Original filed
Dec 23, 2021

This filing lists 1 non-derivative transaction. Open-market sales total $11.9K. It was filed 57 days after the trade.

This amendment replaces 0001437749-21-029225 (filed Dec 23, 2021).

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Wichterman TroyCIK 0001892616Officer (Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 22, 2021Common StockSSaleDisposed−310$38.49−$11,931.922,122Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

F2

On December 23, 2021, the reporting person filed a Form 4 which inadvertently reported in Column 4 of Table I that the sale to cover transaction was an acquisition of securities rather than a disposition of securities. In fact, as reported in this amendment, the reporting person disposed of those shares.

Read the full filing on SEC EDGAR (opens in a new tab)